rs1078423

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_130466.4(UBE3B):​c.2923-1207A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0803 in 152,276 control chromosomes in the GnomAD database, including 1,110 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.080 ( 1110 hom., cov: 32)

Consequence

UBE3B
NM_130466.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.204

Publications

1 publications found
Variant links:
Genes affected
UBE3B (HGNC:13478): (ubiquitin protein ligase E3B) The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin-protein ligases. This gene encodes a member of the E3 ubiquitin-conjugating enzyme family which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme and transfers the ubiquitin to the targeted substrates. A HECT (homology to E6-AP C-terminus) domain in the C-terminus of the longer isoform of this protein is the catalytic site of ubiquitin transfer and forms a complex with E2 conjugases. Shorter isoforms of this protein which lack the C-terminal HECT domain are therefore unlikely to bind E2 enzymes. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2012]
UBE3B Gene-Disease associations (from GenCC):
  • oculocerebrofacial syndrome, Kaufman type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, G2P, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.217 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_130466.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UBE3B
NM_130466.4
MANE Select
c.2923-1207A>C
intron
N/ANP_569733.2
UBE3B
NM_183415.3
c.2923-1207A>C
intron
N/ANP_904324.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UBE3B
ENST00000342494.8
TSL:1 MANE Select
c.2923-1207A>C
intron
N/AENSP00000340596.3
UBE3B
ENST00000434735.6
TSL:1
c.2923-1207A>C
intron
N/AENSP00000391529.2
UBE3B
ENST00000449510.6
TSL:5
n.*904-1207A>C
intron
N/AENSP00000395802.2

Frequencies

GnomAD3 genomes
AF:
0.0801
AC:
12193
AN:
152158
Hom.:
1097
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.220
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0989
Gnomad ASJ
AF:
0.00663
Gnomad EAS
AF:
0.0666
Gnomad SAS
AF:
0.0147
Gnomad FIN
AF:
0.0118
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0124
Gnomad OTH
AF:
0.0669
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0803
AC:
12234
AN:
152276
Hom.:
1110
Cov.:
32
AF XY:
0.0788
AC XY:
5868
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.220
AC:
9157
AN:
41538
American (AMR)
AF:
0.0996
AC:
1524
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00663
AC:
23
AN:
3470
East Asian (EAS)
AF:
0.0662
AC:
343
AN:
5180
South Asian (SAS)
AF:
0.0145
AC:
70
AN:
4824
European-Finnish (FIN)
AF:
0.0118
AC:
125
AN:
10620
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0124
AC:
845
AN:
68026
Other (OTH)
AF:
0.0662
AC:
140
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
501
1002
1502
2003
2504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0572
Hom.:
93
Bravo
AF:
0.0943
Asia WGS
AF:
0.0450
AC:
158
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
1.0
DANN
Benign
0.47
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1078423; hg19: chr12-109970064; API